LEXICON PHARMACEUTICALS PROVIDES UPDATE ON BASELINE PATIENT CHARACTERISTICS FOR PIVOTAL PHASE 3 SONATA-HCM STUDY OF SOTAGLIFLOZIN IN SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY

Reuters · 2d ago

Please log in to view news